Sangamo Therapeutics (NASDAQ:SGMO) Rating Lowered to “Sell” at Wall Street Zen
Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Friday. Several other brokerages have also issued reports on SGMO. Royal Bank of Canada reissued a “sector perform” rating and set a $2.00 target price on […]
Sangamo Therapeutics (NASDAQ:SGMO – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Friday. Several other brokerages have also issued reports on SGMO. Royal Bank of Canada reissued a “sector perform” rating and set a $2.00 target price on […]
